The soluble vcam-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation

HIGHLIGHTS

• who: Sook-Kyoung Heo from the We included , patients with a hematologic malignancy or bone marrow failure syndrome who had undergone HCT at the Ulsan University Hospital in Korea between , and Cell-free serum samples had been collected weekly on days, , +, and + , (pre- and post-HCST) from these subjects. All included patients gave informed consent for blood collection and analysis of their clinical data, and this study was performed in accordance with the Declaration of Helsinki and approved by the Ulsan University Hospital Institutional Review Board (UUH, ). Cytokine profiling antibody arrays have published the paper: The soluble . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.